En esta página
ARTV Artiva Biotherapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$6,83
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,71mínimo 52 semanas
$14,53máximo 52 semanas
Capitalización Bursátil (MRQ)
$333M
P/E
-1.3
BPA
$-3.43
Ingresos
$0
tus insignias
Rango 52S
$3–$15
Calificación del Analista
BUY
Precio Objetivo
$36
P/E
-1.3
ROE
·
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ARTV Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.83
Capitalización Bursátil (MRQ)
$333M
P/E
-1.3
BPA
$-3.43
Ingresos
$0
Rango 52S
$3–$15
ARTV Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02023-12-31 → 2025-12-31
BPA$-3.432023-12-31 → 2025-12-31
Flujo de caja libre·2024-12-31 → 2024-12-31
Margen neto·2024-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ARTV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.3 | · | · | · | |
| P/C (MRQ) | 1.0 | · | 2.2 | Infravalorado | |
| Precio / FCF (TTM) | -4.3 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -4.4 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.9 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ARTV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 24.2 | · | 5.3 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | ARTV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -99.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | ARTV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-1.7%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 27, 2026 | $-0.63 | $-0.64 | 1.2% |
| 31 de marzo de 2026 | May 7, 2026 | $-0.95 | $-0.89 | -6.8% |
| 31 de diciembre de 2025 | $-0.85 | $-0.84 | -0.84% | |
| 30 de septiembre de 2025 | $-0.88 | $-0.89 | 0.83% | |
| 30 de junio de 2025 | $-0.87 | $-0.82 | -5.7% | |
| 31 de marzo de 2025 | $-0.83 | $-0.72 | -14.5% | |
| 31 de diciembre de 2024 | $-0.66 | $-0.77 | 14.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | · | $7.68 | · | |
| Revenue / Share | · | $0.02 | · | |
| Cash Flow / Share | · | $-4.89 | · | |
| Cash / Share | · | $1.66 | · | |
| EPS (TTM) | $-3.43 | $-5.81 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | $27M | $3M | |
| R&D Expense | $22M | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | $13M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $4M | |
| Operating Expenses | $27M | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | $16M | $15M | |
| Operating Income | $-27M | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | $11M | $-12M | |
| Other Non-op | $-1.0K | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | $50.0K | $31.0K | |
| Net Income | $-25M | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | $11M | $-11M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | $13.98 | $-14.09 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | $1.62 | $-14.09 | |
| Shares (Basic) | 39,413,236 | 24,678,420 | · | 24,481,722 | 24,378,823 | 24,341,978 | · | 18,896,829 | 811,210 | 809,758 | · | 806,714 | 800,889 | |
| Shares (Diluted) | 39,413,236 | 24,678,420 | · | 24,481,722 | 24,378,823 | 24,341,978 | · | 18,896,829 | 811,210 | 809,758 | · | 6,967,099 | 800,889 | |
| EBITDA | $-27M | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | · | · | |
| Short-term Investments | $48M | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | · | · | |
| Receivables | · | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | · | · | |
| Prepaid Expense | $3M | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | · | · | |
| Current Assets | $352M | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | · | · | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | · | · | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | · | · | |
| Accum. Depreciation | $10M | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | · | · | |
| Other Non-current Assets | $809.0K | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | · | · | |
| Total Assets | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | · | · | |
| Accounts Payable | $1M | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | · | · | |
| Accrued Liabilities | $10M | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | · | · | |
| Current Liabilities | $15M | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | · | · | |
| Capital Leases | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | · | · | |
| Total Liabilities | $21M | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | · | · | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | · | · | |
| Retained Earnings | $-379M | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | · | · | |
| AOCI | $-21.0K | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | · | · | |
| Stockholders' Equity | $348M | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | · | · | |
| Liabilities + Equity | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | · | · | |
| Shares Outstanding | 48,792,279 | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $692.0K | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | $556.0K | · | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | · | |
| Other Non-cash | · | $307.0K | · | · | · | $-2M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | $-11M | · | |
| CapEx | $415.0K | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | $179.0K | · | |
| Investing Cash Flow | $18M | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | $-493.0K | · | |
| Stock Issued | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $283M | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | $23M | · | |
| Net Change in Cash | $280M | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | $12M | · | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.3% | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | · | · | |
| ROE | -10.1% | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.2 | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | · | · | |
| Quick Ratio | 24.0 | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.12 | $3.55 | · | $5.26 | $6.11 | $6.93 | · | $8.28 | $-234.70 | · | · | · | · | |
| Cash Flow / Share | · | $-0.85 | · | · | · | $-0.82 | · | · | · | · | · | · | · | |
| Cash / Share | $6.18 | $0.85 | · | $1.04 | $1.17 | $1.25 | · | $2.30 | $42.06 | · | · | · | · | |
| EPS (TTM) | $-3.31 | $-3.55 | · | $31.77 | $31.73 | $10.60 | · | $-55.05 | $-52.51 | $-44.60 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $251.0K | $251.0K | · | $251.0K | $251.0K | $251.0K | · | $3M | $29M | $33M | · | · | · | |
| Net Income TTM | $-91M | $-87M | · | $-79M | $-75M | $-72M | · | $-61M | $-33M | $-26M | · | · | · | |
| Market Cap | $473M | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | · | · | |
| P/E | -2.9 | -1.8 | · | 0.1 | 0.0 | 0.3 | · | -0.3 | · | · | · | · | · | |
| P/S | 1885.6 | 634.2 | · | 280.7 | 146.7 | 291.2 | · | 144.3 | · | · | · | · | · | |
| P/B | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | · | · | |
| P / Tangible Book | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | · | · | |
| P / Cash Flow | · | -7.6 | · | · | · | -3.7 | · | · | · | · | · | · | · | |
| Earnings Yield | -34.1% | -55.1% | · | 1107.0% | 2101.3% | 353.3% | · | -356.3% | · | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ingresos | $0 | $251.0K | $33M |
| Margen Operativo % | · | -26805.6% | · |
| Beneficio neto | $-84M | $-65M | $-29M |
| EPS Diluido | $-3.43 | $-5.81 | $-35.78 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ratio corriente | · | 15.4 | · |
| Ratio Rápido | · | 15.1 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Flujo de caja libre | · | $-56M | · |
Propietarios institucionales (13F) 73 declarantes · $392.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
73
Valor en tenencia
$392.5M
Nuevas posiciones
39
Posiciones cerradas
7
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 39 (+27 vs trimestre anterior) | 7 (+2 vs trimestre anterior) | 25 (+22 vs trimestre anterior) | 2 (-10 vs trimestre anterior) | +23.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174 169 727 | 17 955 642 | 44,38% | Acciones |
| VIKING GLOBAL INVESTORS LP | $25 260 410 | 2 604 166 | 6,44% | Acciones |
| Blackstone Inc. | $23 313 339 | 2 403 437 | 5,94% | Acciones |
| 5AM Venture Management, LLC | $22 827 049 | 2 353 304 | 5,82% | Acciones |
| Venrock Adviser, LLC | $19 822 881 | 2 043 596 | 5,05% | Acciones |
| FRANKLIN RESOURCES INC | $19 373 063 | 1 997 223 | 4,94% | Acciones |
| Caligan Partners LP | $16 840 277 | 1 736 111 | 4,29% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 523 606 | 981 815 | 2,43% | Acciones |
| SAMSARA BIOCAPITAL, LLC | $9 262 152 | 954 861 | 2,36% | Acciones |
| Blue Owl Capital Holdings LP | $8 483 057 | 874 542 | 2,16% | Acciones |
| Propel Bio Management, LLC | $6 755 429 | 696 436 | 1,72% | Acciones |
| BlackRock, Inc. | $6 738 842 | 694 726 | 1,72% | Acciones |
| CITADEL ADVISORS LLC | $5 910 947 | 609 376 | 1,51% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5 092 500 | 525 000 | 1,30% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 433 947 | 353 845 | 0,87% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $3 049 438 | 314 375 | 0,78% | Acciones |
| Nantahala Capital Management, LLC | $2 910 000 | 300 000 | 0,74% | Acciones |
| Revelation Capital Management, LLC | $2 903 317 | 299 311 | 0,74% | Acciones |
| Alyeska Investment Group, L.P. | $2 654 066 | 273 615 | 0,68% | Acciones |
| ACUTA CAPITAL PARTNERS, LLC | $2 526 035 | 260 416 | 0,64% | Acciones |
| KVP Capital Advisors, LP | $1 940 000 | 200 000 | 0,49% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 882 848 | 194 108 | 0,48% | Acciones |
| UBS Group AG | $1 784 994 | 184 020 | 0,45% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $1 697 500 | 175 000 | 0,43% | Acciones |
| STATE STREET CORP | $1 607 911 | 165 764 | 0,41% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 464 700 | 151 000 | 0,37% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 439 412 | 148 393 | 0,37% | Acciones |
| ADAR1 Capital Management, LLC | $1 150 653 | 118 624 | 0,29% | Acciones |
| VANGUARD GROUP INC | $1 055 366 | 246 006 | 0,27% | Acciones |
| Simplify Asset Management Inc. | $983 144 | 101 355 | 0,25% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $824 500 | 85 000 | 0,21% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $762 178 | 78 575 | 0,19% | Acciones |
| NORTHERN TRUST CORP | $741 303 | 76 423 | 0,19% | Acciones |
| DAFNA Capital Management LLC | $650 880 | 67 101 | 0,17% | Acciones |
| Quadrature Capital Ltd | $478 647 | 49 345 | 0,12% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $434 705 | 44 815 | 0,11% | Acciones |
| XTX Topco Ltd | $412 337 | 42 509 | 0,11% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $301 796 | 31 113 | 0,08% | Acciones |
| Velan Capital Investment Management LP | $242 500 | 25 000 | 0,06% | Acciones |
| Atom Investors LP | $221 684 | 22 854 | 0,06% | Acciones |
| BAILARD, INC. | $200 790 | 20 700 | 0,05% | Acciones |
| Spark Investment Management LLC | $160 050 | 16 500 | 0,04% | Acciones |
| GOLDMAN SACHS GROUP INC | $153 066 | 15 780 | 0,04% | Acciones |
| Squarepoint Ops LLC | $144 094 | 14 855 | 0,04% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $135 606 | 13 980 | 0,03% | Acciones |
| Vanguard Global Advisers, LLC | $116 187 | 11 978 | 0,03% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $115 391 | 11 896 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $59 170 | 6 100 | 0,02% | Acciones |
| Russell Investments Group, Ltd. | $56 852 | 5 861 | 0,01% | Acciones |
| WELLS FARGO & COMPANY/MN | $53 156 | 5 480 | 0,01% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 23 de julio de 2026 | 37,90% | Enmienda | · | SEC |
| GC Corp, GC Cell Corporation, Yong-Jun Huh | 28 de mayo de 2026 | 12,30% | Enmienda | · | SEC |
| GC Corp., GC Cell Corporation, Yong-Jun Huh | 29 de julio de 2024 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 17 insiders · 9 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | 15 de septiembre de 2026 A | 1 604 765 | 0 | 6 | $-1 384 500 |
| Thad Allen Huston | Chief Financial Officer | 10 de marzo de 2026 A | 220 000 | 0 | 0 | $0 |
| Neha Krishnamohan | Chief Financial Officer | 15 de noviembre de 2025 F | 99 356 | 0 | 0 | $0 |
| Gines Diego Miralles | President & Head of R&D | 9 de septiembre de 2026 A | 122 500 | 0 | 0 | $0 |
| Jennifer Bush | COO, CLO, Compliance Officer | 9 de septiembre de 2026 A | 374 529 | 0 | 2 | $-172 842 |
| Subhashis Banerjee | Chief Medical Officer | 9 de septiembre de 2026 A | 170 947 | 0 | 4 | $-179 573 |
| Christopher Horan | Chief Tech Operations Officer | 9 de septiembre de 2026 A | 323 084 | 0 | 2 | $-178 773 |
| Heather Raymon | SVP, Research and Development | 19 de mayo de 2026 S | 148 228 | 0 | 1 | $-27 886 |
| Thorsten Graef | Chief Medical Officer | 26 de febrero de 2025 A | 80 000 | 0 | 0 | $0 |
| Daniel G. Baker | Consejero | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Laura Stoppel | Consejero | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Elaine K. Sorg | Consejero | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Alison Moore | Consejero | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Brian Daniels | Consejero | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| HOUGEN ELIZABETH L | Consejero | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Yong-Jun Huh | Consejero | 22 de julio de 2024 C | 1 260 512 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 22 de julio de 2024 C | 194 108 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 12 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 15 680 SH | 11 de septiembre de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 138 068 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 2 230 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 13 050 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 3 029 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 5 863 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 269 149 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 699 899 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26 837 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 934 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 342 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 35 940 SH | 11 de septiembre de 2026 | Diario |
ARTV Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 12 analistas
COMPRA
Objetivo mediano
$40.00
+485,7%
4 33,3%
Compra fuerte
7 58,3%
Compra
1 8,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
5 analistas · 2026-09-29Objetivo medio $35.80 +424,2%
← Por Debajo de Todos los Objetivos
Precio Actual $6.83
Mín$23.00
Media$35.80
Máx$41.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ARTV | · | -1.3 | -99.2% | · | · | · |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| SRZN | · | · | · | · | · | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| SCTX | · | · | · | · | · | · |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026